SWAN Venture Group (often abbreviated SVG) is a **regional early-stage venture capital group based in Kirkland, Washington, USA focused on backing seed and early institutional companies across the Pacific Northwest (WA, ID, MT, AK, UT) and nearby Canadian markets like British Columbia. It’s structured as a family of funds that invests into startups from seed through Series A with support from experienced investor partners.

Pre-Seed / Seed: Primary focus — early institutional capital where SVG often acts as one of the first major outside investors.
Series A: Participates opportunistically in Series A rounds via its institutional fund.

Typical Investment Size: SVG’s funds, such as its Seed/Pre-Seed funds, typically deploy ~$200K–$1.2M+ in early rounds dependent on needs and fund size.
Equity Taken:
• SVG does not publish a fixed target equity percentage, and like most early-stage VC funds, ownership is negotiated per deal based on valuation, how much they invest, and the overall round size.
• Founder-side expectations (industry standard context): For a lead or meaningful co-lead early institutional check in a seed round (e.g., $500K–$1.2M+), a professional investor typically ends up with a meaningful minority stake (~8%–15%) after pricing, though exact percentages vary widely with valuation and total capital raised.
• SVG’s ownership outcome in any specific company depends on valuation negotiation, syndicate size, and how much SVG funds contribute relative to others.
Equity Structure: Standard priced preferred equity or early convertible instruments depending on deal structure.
Governance: With meaningful participation, SVG typically negotiates standard governance rights, which may include observer or board seats where appropriate.

Submission Method: SVG accepts founder outreach through its website lead/contact form; direct outreach or warm intros via ecosystem partners are common pathways. 

Sector Focus: Broad technology and scalable sectors including B2B software, market-accelerating technologies, capital-efficient hard science, diagnostics, health IT/medical devices, and related early technology areas.
Geography: Pacific Northwest (U.S.) and adjacent Canadian markets; globally located companies may be considered if they align with fund strategy and local investor interest.
Stage: Pre-seed, seed, and Series A. 
Company Profile: Innovative founders with early traction, defensible product/market, and growth potential.

Initial Intake & Screening: Review of executive summary, team, traction, and market fit.
 Partner Evaluation: Internal analysis and partner meetings to assess fit with SVG funds’ thesis.
 Due Diligence: Market, product, team, and competitive diligence.
 Term Negotiation: Valuation, equity rights, and governance terms finalized with founders and any co-investors. 

Strategic Capital: Seed and early institutional funding to support product scaling, hiring, and go-to-market. 
 Network & Mentorship: Access to a regional group of experienced investors and business operators with local insights. 
 Follow-On Support: Potential participation in Series A or later rounds via SVG’s institutional fund vehicles.